NCT02739607

Brief Summary

Objectives

  1. 1.To test the effectiveness and acceptability of an augmented internet-supported transdiagnostic intervention in Romania.
  2. 2.To assess the cost-effectiveness of the Internet version of the transdiagnostic program as compared to a standard treatment/usual care.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable depression

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 15, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

May 6, 2016

Status Verified

May 1, 2016

Enrollment Period

5 months

First QC Date

April 12, 2016

Last Update Submit

May 5, 2016

Conditions

Keywords

emotional disordersinternet-delivered interventionanxietydepressiontransdiagnostic

Outcome Measures

Primary Outcomes (6)

  • Penn State Worry Questionnaire (PSWQ)

    The PSWQ was designed to measure participant's level of generalized anxiety or worry. The scale is unidimensional and the total score rages from 16 to 80. Low scores are associated with low levels of worry, while high scores are associated with high levels of worry.

    Absolute values (average score) of PSWQ at 11 weeks (post-intervention)

  • Social Phobia Inventory (SPIN)

    The SPIN was designed to measure participant's level of social phobia. The scale is unidimensional and the total score rages from 0 to 68. Low scores are associated with low levels of social phobia, while high scores are associated with high levels of social phobia.

    Absolute values (average score) of SPIN at 11 weeks (post-intervention)

  • Yale-Brown Obsessive Compulsive Scale (YBOCS)

    The YBOCS was designed to measure participant's level of obsessions and compulsions (O\&C). The scale total score rages from 0 to 40. Low scores are associated with low levels of O\&C, while high scores are associated with high levels of O\&C.

    Absolute values (average score) of YBOCS at 11 weeks (post-intervention)

  • Panic Disorder Severity Scale - Self Report (PDSS-SR)

    The PDSS-SR was designed to measure participant's level of panic. The scale is unidimensional and the total score rages from 0 to 28. Low scores are associated with low levels of panic, while high scores are associated with high levels of panic.

    Absolute values (average score) of PDSS-SR at 11 weeks (post-intervention)

  • Post-Traumatic Stress Disorder Checklist for the Diagnostic and Statistical Manual-5 (PCL-5)

    The PCL-5 was designed to measure participant's level of post-traumatic stress. The scale is unidimensional and the total score rages from 0 to 80. Low scores are associated with low levels of post-traumatic stress, while high scores are associated with high levels of post-traumatic stress.

    Absolute values (average score) of PCL-5 at 11 weeks (post-intervention)

  • Beck Depression Inventory-II (BDI-II)

    The Beck Depression Inventory-II (BDI-II) was designed to measure participant's level of depression. The scale is unidimensional and the total score rages from 0 to 63. Low scores are associated with low levels of depression, while high scores are associated with high levels of depression.

    Absolute values (average score) of BDI-II at 11 weeks (post-intervention)

Secondary Outcomes (4)

  • Emotion Regulation Questionnaire (ERQ)

    Absolute values (average score) of ERQ at 11 weeks (post-intervention)

  • Anxiety Sensitivity Index (ASI)

    Absolute values (average score) of ASI at 11 weeks (post-intervention)

  • Beck Anxiety Inventory (BAI)

    Absolute values (average score) of Treatment satisfaction and acceptability at 11 weeks (post-intervention)

  • Almost Perfect Scale-Revised (APS-R)

    Absolute values (average score) of APS-R at 11 weeks (post-intervention)

Study Arms (2)

Transdiagnostic program

EXPERIMENTAL

This arm represents the Transdiagnostic intervention program for emotional disorders. The intervention, based on the Cognitive Behavioral Therapy (CBT) principles, is designed to encourage participants to confront and experience uncomfortable emotions, and use adaptive coping mechanisms.

Behavioral: Transdiagnostic program

Wait list control group

NO INTERVENTION

This arm represents the wait-list comparison group.

Interventions

This transdiagnostic program is based on the general Cognitive Behavioral Therapy (CBT) principles and targets core higher order factors such as negative affectivity and emotion dysregulation, using common intervention techniques applicable across disorders. The program was designed to directly address the aversive emotional experiences often reported by clients, hoping to reverse participants' maladaptive thinking style and dysfunctional behaviors.

Transdiagnostic program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be fluent in Romanian
  • be over 18 years
  • have the principal diagnostic of generalized anxiety disorder and/or obsessive-compulsive disorder and/or panic disorder and/or social anxiety disorder and/or major depression disorder and/or dysthymia (or any combination of these diagnostics) on Structured Clinical Interview for the Diagnostic and Statistical Manual for Mental Disorders (SCID-I)
  • have access to an Internet connected computer

You may not qualify if:

  • suicidal ideation
  • ongoing psychological treatment for generalized anxiety disorder and/or obsessive-compulsive disorder and/or panic disorder and/or social anxiety disorder and/or major depression disorder and/or dysthymia
  • other primary disorder that need treatment
  • obstacle to participation (i.e., long travel plans)
  • recent change in psychiatric medication (i.e., during the last 6 weeks)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West University of Timisoara

Timișoara, Timiș County, 300223, Romania

RECRUITING

Related Publications (1)

  • Tulbure BT, Rusu A, Sava FA, Salagean N, Farchione TJ. A Web-Based Transdiagnostic Intervention for Affective and Mood Disorders: Randomized Controlled Trial. JMIR Ment Health. 2018 May 24;5(2):e36. doi: 10.2196/mental.8901.

Related Links

MeSH Terms

Conditions

DepressionDysthymic DisorderPanic DisorderPhobia, SocialPhobia, SpecificObsessive-Compulsive DisorderGeneralized Anxiety DisorderAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorDepressive DisorderMood DisordersMental DisordersPhobic Disorders

Study Officials

  • Bogdan T Tulbure, PhD

    West University of Timisoara

    STUDY DIRECTOR

Central Study Contacts

Bogdan Tudor Tulbure, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2016

First Posted

April 15, 2016

Study Start

April 1, 2016

Primary Completion

September 1, 2016

Study Completion

March 1, 2017

Last Updated

May 6, 2016

Record last verified: 2016-05

Data Sharing

IPD Sharing
Will not share

Data will be process only at the group level. No individual data will be shared to third parties.

Locations